How NHS spending, technology adoption, and clinical outcomes vary across England. Written for MedTech, diagnostics, and digital health teams navigating UK market access.
What select committees, Hansard debates, and written evidence tell us about the direction of NHS policy.
Which technologies are actually getting adopted in the NHS, how they get through, and what separates success from perpetual piloting.
Why publicly funded breakthroughs stall between the lab and the patient.
How disease burden, clinical capacity, and outcomes vary across England.
Where NHS spending goes, how it's changing, and what it means for health technology.
We help MedTech companies, diagnostics firms, and health-AI startups understand the NHS landscape — so you can build the evidence case for adoption.
Start a conversation →